Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP-1”

1,279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,279 results

Testing effectiveness (Phase 2)Study completedNCT00797823
What this trial is testing

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

Who this might be right for
Type 1 Diabetes
Legacy Health System 14
Not applicableStudy completedNCT01666223
What this trial is testing

Effect of Bile Acids on GLP-1 Secretion

Who this might be right for
Type 2 DiabetesObesity
University Hospital, Gentofte, Copenhagen 20
Not applicableStudy completedNCT02006459
What this trial is testing

Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal

Who this might be right for
Diabetes
University Hospital, Gentofte, Copenhagen 20
Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Not applicableStudy completedNCT03697486
What this trial is testing

The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese Women

Who this might be right for
PYYGhrelinAppetite+3 more
Indonesia University 22
Testing effectiveness (Phase 2)Looking for participantsNCT05499702
What this trial is testing

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Who this might be right for
Type2diabetes
Adrian Vella 20
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Not applicableLooking for participantsNCT07195994
What this trial is testing

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Who this might be right for
Prediabetes / Type 2 Diabetes
QuickSilver Scientific 90
Very early researchWithdrawnNCT04133922
What this trial is testing

Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesInsulin Sensitivity/Resistance
University of Virginia
Not applicableStudy completedNCT02181127
What this trial is testing

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Who this might be right for
Type 1 Diabetes
Massachusetts General Hospital 31
Post-approval studies (Phase 4)Looking for participantsNCT06901245
What this trial is testing

Tirzepatide in PWS, HO and GNSO

Who this might be right for
Prader-Willi SyndromeHypothalamic ObesityObesity/Therapy
Grace Kim 36
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Not applicableStudy completedNCT02509065
What this trial is testing

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Massachusetts General Hospital 24
Not applicableStudy completedNCT01607931
What this trial is testing

Exercise, Glucose Kinetics, and the Incretin Effect

Who this might be right for
Type 2 Diabetes
Rigshospitalet, Denmark 12
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Early research (Phase 1)Active Not RecruitingNCT06923839
What this trial is testing

Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men

Who this might be right for
Healthy Male Adults
Oluf Pedersen 15
Testing effectiveness (Phase 2)Ended earlyNCT01298830
What this trial is testing

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage (ICH)
CellMed AG, a subsidiary of BTG plc. 11
Load More Results